Lantern Pharma Inc. — Investor Relations & Filings
Filings indexed
230
across all filing types
Latest filing
2020-06-17
Director's Dealing
Country
US
United States of America
Listing
US
LTRN
Lantern Pharma is a clinical-stage pharmaceutical company focused on transforming oncology drug development through the use of artificial intelligence (AI), machine learning, and genomics. The company's data-driven platform is designed to reduce the cost, time, and risk associated with creating new cancer therapies. It works by identifying specific patient biomarkers to predict drug response, enabling the development of precision medicines with novel mechanisms of action. Lantern Pharma's pipeline consists of targeted drug candidates for various cancers, aiming to improve clinical trial success rates and patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRIMARY DOCUMENT | 2020-06-17 | English | |
| CURRENT REPORT | 2020-06-17 | English | |
| PRIMARY DOCUMENT | 2020-06-17 | English | |
| Regulatory Filings 2020 | 2020-06-16 | English | |
| Director's Dealing 2020 | 2020-06-15 | English | |
| Director's Dealing 2020 | 2020-06-15 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 13159040 | PRIMARY DOCUMENT | 2020-06-17 | English | ||
| 13159038 | CURRENT REPORT | 2020-06-17 | English | ||
| 13159041 | PRIMARY DOCUMENT | 2020-06-17 | English | ||
| 13159043 | Regulatory Filings 2020 | 2020-06-16 | English | ||
| 13159042 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159044 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159045 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159046 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159047 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159049 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159048 | Director's Dealing 2020 | 2020-06-15 | English | ||
| 13159050 | OWNERSHIP DOCUMENT | 2020-06-15 | English | ||
| 13159051 | OWNERSHIP DOCUMENT | 2020-06-15 | English | ||
| 13159052 | PROSPECTUS | 2020-06-12 | English | ||
| 13159053 | REGISTRATION STATEMENT | 2020-06-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lantern Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34585/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34585 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34585 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34585 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34585}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lantern Pharma Inc. (id: 34585)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.